49 related articles for article (PubMed ID: 16499087)
1. [Metabolic kinetics of MN9202 in Beagle dog liver microsomes].
Yang ZF; Zhou SY; Mei QB; Yang TH; Liu ZG
Yao Xue Xue Bao; 2005 Nov; 40(11):1019-23. PubMed ID: 16499087
[TBL] [Abstract][Full Text] [Related]
2. Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes.
Liu XQ; Ren YL; Qian ZY; Wang GJ
Acta Pharmacol Sin; 2000 Aug; 21(8):690-4. PubMed ID: 11501176
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and metabolic inhibition of cilnidipine in human liver microsomes.
Liu XQ; Zhao Y; Li D; Qian ZY; Wang GJ
Acta Pharmacol Sin; 2003 Mar; 24(3):263-8. PubMed ID: 12617777
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic kinetic of puerarin in beagle liver microsomal by HPLC-ESI-MS].
Wen BY; Li H; Wang L; Wang SC
Zhongguo Zhong Yao Za Zhi; 2008 Dec; 33(23):2834-7. PubMed ID: 19260325
[TBL] [Abstract][Full Text] [Related]
5. [In vivo comparison of estradiol metabolism in liver microsomes of human, Beagle dog and rat].
Song YQ; Liao J; Liu HW; Ai CH; Zhang F
Yao Xue Xue Bao; 2012 Feb; 47(2):210-5. PubMed ID: 22512033
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions.
Haaz MC; Rivory L; Riché C; Vernillet L; Robert J
Cancer Res; 1998 Feb; 58(3):468-72. PubMed ID: 9458091
[TBL] [Abstract][Full Text] [Related]
7. CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes.
Zhao XP; Zhong J; Liu XQ; Wang GJ
Acta Pharmacol Sin; 2007 Jan; 28(1):118-24. PubMed ID: 17184591
[TBL] [Abstract][Full Text] [Related]
8. Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
Marre F; Sanderink GJ; de Sousa G; Gaillard C; Martinet M; Rahmani R
Cancer Res; 1996 Mar; 56(6):1296-302. PubMed ID: 8640817
[TBL] [Abstract][Full Text] [Related]
9. [Metabolism of 3-cyanomethyl-4-methyl-DCK, a new anti-HIV candidate, in human intestinal microsomes].
Zhuang XM; Wen YY; Li H; Deng JT; Kong WL; Tian XT; Cui SL; Xie L
Yao Xue Xue Bao; 2010 Sep; 45(9):1116-22. PubMed ID: 21351567
[TBL] [Abstract][Full Text] [Related]
10. Different pharmacological properties of the optical isomers of MN9202, a novel 1,4-dihydropyridine Ca+ channel modulator, in rat ventricular myocytes.
Li XQ; Cao W; Zeng AG; Yang ZF; Xing B; Dong L; Zhang HF; Mei QB
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):817-25. PubMed ID: 20374262
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19.
Giraud C; Tran A; Rey E; Vincent J; Tréluyer JM; Pons G
Drug Metab Dispos; 2004 Nov; 32(11):1279-86. PubMed ID: 15483195
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
Taavitsainen P; Juvonen R; Pelkonen O
Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487
[TBL] [Abstract][Full Text] [Related]
14. Clomipramine N-demethylation metabolism in human liver microsomes.
Wu ZL; Huang SL; Ou-Yang DS; Xu ZH; Xie HG; Zhou HH
Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):433-6. PubMed ID: 10375803
[TBL] [Abstract][Full Text] [Related]
15. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
Wester MR; Lasker JM; Johnson EF; Raucy JL
Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of alfentanil by cytochrome p4503a (cyp3a) enzymes.
Klees TM; Sheffels P; Dale O; Kharasch ED
Drug Metab Dispos; 2005 Mar; 33(3):303-11. PubMed ID: 15557344
[TBL] [Abstract][Full Text] [Related]
17. [In vitro comparison of thienorphine metabolism in liver microsomes of human, Beagle dog and rat].
Deng JT; Zhuang XM; Li H
Yao Xue Xue Bao; 2010 Jan; 45(1):98-103. PubMed ID: 21351457
[TBL] [Abstract][Full Text] [Related]
18. Diazinon is activated by CYP2C19 in human liver.
Kappers WA; Edwards RJ; Murray S; Boobis AR
Toxicol Appl Pharmacol; 2001 Nov; 177(1):68-76. PubMed ID: 11708902
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation.
Obach RS
Drug Metab Dispos; 2000 Sep; 28(9):1069-76. PubMed ID: 10950851
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes.
Haaz MC; Riché C; Rivory LP; Robert J
Drug Metab Dispos; 1998 Aug; 26(8):769-74. PubMed ID: 9698291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]